A.Yu. Lebedeva - Dr.Sc.(Med.), State Educational Institution of VPO Russian National Medical Research University n.a. N.I. Pirogov, Moscow

Cardiovascular diseases are among the most urgent problems of present-day medicine. The ischemic disease of the heart is among the most widespread cardiovascular pathologies. The death rate of this illness ranks high worldwide. The most severe patients had exertion stenocardia of the third and fourth functional classes and rest stenocardia complicated by one or several stenotic coronary arteries. Although these patients received great doses of nitrates, beta adrenoblockers, calcium antagonists, and disaggregants, the treatment appeared ineffective. By the end of a MM-wave therapy course, 80% of the patients revealed a positive clinical effect. The application of MM waves reduced the number of episodes of painful and painless myocardial ischemia. Hence, MM-wave therapy produced both painkilling and antianginal effects. Unstable stenocardia is classified among acute ischemic diseases of the heart. It is especially dangerous in the case of an abrupt onset (within a few days) or intensifying anginal attacks. Unstable stenocardia may take a bad course, resulting in myocardial infarction, sudden death, or chronic stenocardia. The clinical application of MM-wave therapy was found to be effective in 60% of the cases. The treatment was successful even when MM waves were used as a monotherapy. Being combined with pharmacotherapy, MM-wave therapy increased the rate of positive clinical effects. The conducted therapy produced favorable effects in every patient of the examined group. Myocardial infarction is the most severe ischemic disease of the heart. At the acute stage, it is most dangerous for the patient to develop such complications as a cardiac-rhythm disorder or acute left ventricular failure. Serious postinfarction complications include the development of chronic circulatory deficiency and early postinfarction stenocardia. When MM-wave therapy was administered within the first hours of myocardial infarction and its complications, it decreased the number of episodes of acute left ventricular failure. It also decreased the rate of postinfarction stenocardia and chronic circulatory deficiency.